OrthoPediatrics Corp

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -3.99 M-4.16 M-10.46 M-581 K10.35 M -4.85 M Mittelzufluss aus Investitionstätigkeit -2.41 M-5.99 M-3.54 M-26.84 M-7.26 M -43.63 M Zahlungsströme aus der Finanzierungstätigkeit -541 K-126 K24.8 M-282 K-417 K 23.98 M Freier Cashflow -3.73 M-8.38 M-13.91 M-3.42 M9.75 M -15.96 M

OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.

KIDS

Financials

OrthoPediatrics Corp

Nachrichten

OrthoPediatrics sichert sich neue Darlehensfazilität über 20 Millionen US-Dollar

OrthoPediatrics at Citizens Life Sciences: Pediatric Growth Strategy Unveiled

OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?

Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?

OrthoPediatrics: Needham hebt Kursziel wegen Wachstumsaussichten auf 30 US-Dollar an

Needham raises OrthoPediatrics stock price target to $30 on growth

OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

Meta Goes to Trial in a New Mexico Child Safety Case. Here’s What’s at Stake

iotaMotion erhält FDA-Zulassung für pädiatrisches Cochlea-Implantat-System

FDA clears iotaMotion’s cochlear implant system for children from age four

TD Cowen startet Coverage für OrthoPediatrics mit Kaufempfehlung